Pathophysiology of idiopathic normal pressure hydrocephalus (part 2): cerebral blood flow and ischemia of the deep white matter
DOI:
https://doi.org/10.31157/an.v21i1.111Keywords:
idiopathic normal pressure hydrocephalus, deep white matter isquemia, cerebral blood flow, β-amyloid depositionAbstract
In the development of the Idiopathic Normal Pressure Hydrocephalus (iNPH), there are multiple factors involved in the disease establishment, one of them that the literature most supports is the alteration in brain blood flow and the ischemia of the deep white matter, These changes can be caused by a previous events of cerebrovascular disease, amyloid angiopathy, and sclerotic medullary arteries (perforating arteries of the deep white matter). Looking carefully we will see that these changes are usually regional and emphasize mainly in the vessels of the basal ganglia and periventricular (Deep White Matter). In turn, these changes in regional flow will bring us consequences as edema, accumulation of waste products such as beta-amyloid (βa), contributing to chronic hypoxia. One of the questions that can be discussed in this issue is whether the changes in blood flow are the cause of these disorders or simply an epiphenomenon. Other authors refer to another simultaneous failure of toxic waste products such as βa factor are Neurovascular damage (NVU) Unit, this damage is often seen in Alzheimer’s Disease and hence one of the reasons why there comorbidity with iNPH.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2016 Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez
This work is licensed under a Creative Commons Attribution 4.0 International License.
September 2022-present © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January-September 2022 © The authors. Open access articles under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. No commercial re-use is allowed.
January 2014-December 2021 © Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez. Open access articles under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.